Shilpa Medicare Ltd (SHILPAMED) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 780523,
    "name": "Shilpa Medicare",
    "stock_name": "Shilpa Medicare",
    "full_name": "Shilpa Medicare Ltd",
    "name_url": "stocks-analysis/shilpa-medicare",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "299.05",
    "chg": 11.85,
    "chgp": "4.13%",
    "dir": 1,
    "prev_price": "287.20",
    "mcapval": "5,895.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530549,
    "symbol": "SHILPAMED",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE790G01031",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "5.22 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/shilpa-medicare-780523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Shilpa Medicare falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-shilpa-medicare-fallingrising-3736153",
        "imagepath": "",
        "date": "2025-11-29 00:48:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>On 28 November, Shilpa Medicare’s shares fell by ₹7.10, or 2.03%, closing at ₹342.00. This decline is part of a broader trend, with the stock underperforming the Sensex and its sector over multiple time frames. Over the past week, the stock has dropped 2.51%, while the Sensex gained 0.56%. The one-month performance shows a 5.11% loss for Shilpa Medicare against a 1.27% rise in the Sensex. Year-to-date, the stock has declined 15.87%, contrasting with the Sensex’s 9.68% gain. Over the last year, the stock’s fall is even more pronounced at 23.74%, while the Sensex rose 8.43%. These figures highlight a persistent underperformance relative to the broader market.</p>\n<p>Intraday trading on 28 November saw the stock touch a low of ₹340.20,..."
      },
      {
        "title": "Shilpa Medicare Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-downgraded-to-strong-sell-amid-mixed-financial-and-technical-signals-3717103",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ShilpaMedicare_mojoScore_3717103.png",
        "date": "2025-11-20 08:11:15",
        "description": "Shilpa Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation following recent financial disclosures and technical analysis. While the company’s quarterly results indicate positive trends in profitability and operational efficiency, certain long-term fundamentals and technical indicators suggest a cautious outlook for investors."
      },
      {
        "title": "Why is Shilpa Medicare falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-shilpa-medicare-fallingrising-3716291",
        "imagepath": "",
        "date": "2025-11-19 22:50:19",
        "description": "As of 19-Nov, Shilpa Medicare Ltd is experiencing a decline in its stock price, currently at Rs 360.00, which reflects a decrease of Rs 5.85 or 1.6%. The stock has been underperforming, having fallen consecutively for the last five days, resulting in a total decline of 9.92% over that period. Today's trading saw the stock hit an intraday low of Rs 351.8, and it is currently trading below all its moving averages. Additionally, investor participation has decreased significantly, with delivery volume dropping by 57.17% compared to the five-day average. Despite positive financial results over the last nine quarters, including a substantial increase in profits, the stock has underperformed with a year-to-date return of -11.44% and a one-year return of -18.17%, indicating a disconnect between its strong earnings growth and stock performance.\n\nIn the broader market context, Shilpa Medicare's performance contrasts ..."
      },
      {
        "title": "How has been the historical performance of Shilpa Medicare?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-shilpa-medicare-3716191",
        "imagepath": "",
        "date": "2025-11-19 22:42:45",
        "description": "Answer:\nThe historical performance of Shilpa Medicare shows a significant increase in net sales, reaching 1,286.41 Cr in March 2025, up from 1,151.60 Cr in March 2024 and 1,050.11 Cr in March 2023. The total operating income mirrored this growth, with a rise to 1,286.41 Cr in March 2025. However, total expenditure also increased to 969.51 Cr in March 2025, compared to 907.11 Cr in March 2024. Operating profit (PBDIT) saw a substantial rise to 340.20 Cr in March 2025 from 252.66 Cr in March 2024, indicating improved operational efficiency. Profit before tax improved to 123.60 Cr in March 2025, up from 59.11 Cr in March 2024, while profit after tax also rose to 79.57 Cr from 36.74 Cr. The earnings per share increased to 4.0 in March 2025, compared to 3.67 in March 2024. \n\nOn the balance sheet side, total assets grew to 3,297.74 Cr in March 2025 from 3,082.98 Cr in March 2024, with total liabilities also incre..."
      },
      {
        "title": "Is Shilpa Medicare technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-shilpa-medicare-technically-bullish-or-bearish-3713925",
        "imagepath": "",
        "date": "2025-11-19 08:16:05",
        "description": "As of 18 November 2025, the technical trend for Shilpa Medicare has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this stance include a bearish MACD on the weekly chart, bearish Bollinger Bands, and bearish moving averages on the daily timeframe. The KST is also bearish on the weekly chart, while the Dow Theory shows a mildly bullish signal on the weekly but is mildly bearish on the monthly. Overall, the combination of these indicators suggests a prevailing bearish sentiment in the market...."
      },
      {
        "title": "Shilpa Medicare Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-technical-momentum-shifts-to-bearish-amid-market-pressure-3714291",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ShilpaMedicare_technicaldot_3714291.png",
        "date": "2025-11-19 08:07:38",
        "description": "Shilpa Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent data indicating a transition from mildly bearish to bearish trends. The stock closed at ₹367.05, down 3.18% from the previous close of ₹379.10, reflecting a cautious market stance amid mixed technical signals."
      },
      {
        "title": "Shilpa Medicare Shows Mixed Financial Trends Amidst Strong Performance Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicares-financial-trend-shifts-from-very-positive-to-positive-amid-mixed-results-3701262",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ShilpaMedicare_fintrenddot_3701262.png",
        "date": "2025-11-14 11:02:25",
        "description": "Shilpa Medicare has reported positive financial results for the quarter ending September 2025, showcasing strong metrics such as an 8.57% Return on Capital Employed and net sales of Rs 369.97 crore. Despite challenges with operating cash flow and rising interest expenses, the company has demonstrated resilience in market performance."
      },
      {
        "title": "Shilpa Medicare Q2 FY26: Strong Profit Growth Masks Underlying Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/shilpa-medicare-q2-fy26-strong-profit-growth-masks-underlying-concerns-3713062",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ShilpaMedicare_quaterlyResult_3713062.png",
        "date": "2025-11-14 09:34:52",
        "description": "Shilpa Medicare Ltd., a Raichur-based pharmaceutical company specialising in active pharmaceutical ingredients (APIs) and formulations, reported a consolidated net profit of ₹44.07 crores for Q2 FY26, marking an impressive 145.65% year-on-year growth from ₹17.94 crores in Q2 FY25. However, the sequential performance revealed a 6.01% decline from the previous quarter's ₹46.89 crores, raising questions about sustainability. The stock, currently trading at ₹379.05 with a market capitalisation of ₹7,413.53 crores, has declined 12.74% over the past year, significantly underperforming the Sensex's 8.36% gain."
      },
      {
        "title": "Is Shilpa Medicare technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-shilpa-medicare-technically-bullish-or-bearish-3700357",
        "imagepath": "",
        "date": "2025-11-14 08:13:02",
        "description": "As of 13 November 2025, the technical trend has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by a bearish MACD on the weekly chart and a mildly bearish KST. The daily moving averages also indicate a mildly bearish trend. While the Bollinger Bands show a bullish signal on the monthly timeframe, the overall indicators suggest weakness in the current price action. The Dow Theory indicates a mildly bullish stance on the weekly chart but is mildly bearish on the monthly, reflecting mixed signals. The stock has underperformed compared to the Sensex over the YTD and 1Y periods, further supporting the bearish outlook...."
      }
    ],
    "total": 352,
    "sid": "780523",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/shilpa-medicare-780523"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Board Meeting Intimation Under Regulation 29 Of SEBI (LODR) Regulations 2015",
      "datetime": "30-Jan-2026",
      "details": "Shilpa Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve We hereby wish to inform you that the Meeting of the Board of Directors of Shilpa Medicare Limited is scheduled on Friday 06 February 2026 inter alia to consider and approve unaudited financial results of the Company (Consolidated and Standalone) for the quarter & nine months ended 31 December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "30-Jan-2026",
      "details": "Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith the schedule of 3Q- FY26 Earnings Conference Call which is to be held on Friday 06 February 2026 at 16.00 hrs.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "28-Jan-2026",
      "details": "Press release of Shilpa Biologicals Pvt Ltd a material subsidiary of Shilpa Medicare Limited. and mAb Tree Biologicals on achieving a Major U.S. FDA Milestone as Flagship Breakthrough Biologic secures orphan drug designation for rare blood cancers.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has declared <strong>100%</strong> dividend, ex-date: 17 Sep 25",
          "dt": "2025-09-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has announced <strong>1:2</strong> stock split, ex-date: 06 Nov 15",
          "dt": "2015-11-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 03 Oct 25",
          "dt": "2025-10-03",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Shilpa Medicare falling/rising?

2025-11-29 00:48:53

Recent Price Movement and Market Comparison On 28 November, Shilpa Medicare’s shares fell by ₹7.10, or 2.03%, closing at ₹342.00. This decline is part of a broader trend, with the stock underperforming the Sensex and its sector over multiple time frames. Over the past week, the stock has dropped 2.51%, while the Sensex gained 0.56%. The one-month performance shows a 5.11% loss for Shilpa Medicare against a 1.27% rise in the Sensex. Year-to-date, the stock has declined 15.87%, contrasting with the Sensex’s 9.68% gain. Over the last year, the stock’s fall is even more pronounced at 23.74%, while the Sensex rose 8.43%. These figures highlight a persistent underperformance relative to the broader market. Intraday trading on 28 November saw the stock touch a low of ₹340.20,...

Shilpa Medicare Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-11-20 08:11:15

Shilpa Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation following recent financial disclosures and technical analysis. While the company’s quarterly results indicate positive trends in profitability and operational efficiency, certain long-term fundamentals and technical indicators suggest a cautious outlook for investors.

Why is Shilpa Medicare falling/rising?

2025-11-19 22:50:19

As of 19-Nov, Shilpa Medicare Ltd is experiencing a decline in its stock price, currently at Rs 360.00, which reflects a decrease of Rs 5.85 or 1.6%. The stock has been underperforming, having fallen consecutively for the last five days, resulting in a total decline of 9.92% over that period. Today's trading saw the stock hit an intraday low of Rs 351.8, and it is currently trading below all its moving averages. Additionally, investor participation has decreased significantly, with delivery volume dropping by 57.17% compared to the five-day average. Despite positive financial results over the last nine quarters, including a substantial increase in profits, the stock has underperformed with a year-to-date return of -11.44% and a one-year return of -18.17%, indicating a disconnect between its strong earnings growth and stock performance. In the broader market context, Shilpa Medicare's performance contrasts ...

How has been the historical performance of Shilpa Medicare?

2025-11-19 22:42:45

Answer: The historical performance of Shilpa Medicare shows a significant increase in net sales, reaching 1,286.41 Cr in March 2025, up from 1,151.60 Cr in March 2024 and 1,050.11 Cr in March 2023. The total operating income mirrored this growth, with a rise to 1,286.41 Cr in March 2025. However, total expenditure also increased to 969.51 Cr in March 2025, compared to 907.11 Cr in March 2024. Operating profit (PBDIT) saw a substantial rise to 340.20 Cr in March 2025 from 252.66 Cr in March 2024, indicating improved operational efficiency. Profit before tax improved to 123.60 Cr in March 2025, up from 59.11 Cr in March 2024, while profit after tax also rose to 79.57 Cr from 36.74 Cr. The earnings per share increased to 4.0 in March 2025, compared to 3.67 in March 2024. On the balance sheet side, total assets grew to 3,297.74 Cr in March 2025 from 3,082.98 Cr in March 2024, with total liabilities also incre...

Is Shilpa Medicare technically bullish or bearish?

2025-11-19 08:16:05

As of 18 November 2025, the technical trend for Shilpa Medicare has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this stance include a bearish MACD on the weekly chart, bearish Bollinger Bands, and bearish moving averages on the daily timeframe. The KST is also bearish on the weekly chart, while the Dow Theory shows a mildly bullish signal on the weekly but is mildly bearish on the monthly. Overall, the combination of these indicators suggests a prevailing bearish sentiment in the market....

Shilpa Medicare Technical Momentum Shifts Amid Bearish Signals

2025-11-19 08:07:38

Shilpa Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent data indicating a transition from mildly bearish to bearish trends. The stock closed at ₹367.05, down 3.18% from the previous close of ₹379.10, reflecting a cautious market stance amid mixed technical signals.

Shilpa Medicare Shows Mixed Financial Trends Amidst Strong Performance Metrics

2025-11-14 11:02:25

Shilpa Medicare has reported positive financial results for the quarter ending September 2025, showcasing strong metrics such as an 8.57% Return on Capital Employed and net sales of Rs 369.97 crore. Despite challenges with operating cash flow and rising interest expenses, the company has demonstrated resilience in market performance.

Shilpa Medicare Q2 FY26: Strong Profit Growth Masks Underlying Concerns

2025-11-14 09:34:52

Shilpa Medicare Ltd., a Raichur-based pharmaceutical company specialising in active pharmaceutical ingredients (APIs) and formulations, reported a consolidated net profit of ₹44.07 crores for Q2 FY26, marking an impressive 145.65% year-on-year growth from ₹17.94 crores in Q2 FY25. However, the sequential performance revealed a 6.01% decline from the previous quarter's ₹46.89 crores, raising questions about sustainability. The stock, currently trading at ₹379.05 with a market capitalisation of ₹7,413.53 crores, has declined 12.74% over the past year, significantly underperforming the Sensex's 8.36% gain.

Is Shilpa Medicare technically bullish or bearish?

2025-11-14 08:13:02

As of 13 November 2025, the technical trend has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by a bearish MACD on the weekly chart and a mildly bearish KST. The daily moving averages also indicate a mildly bearish trend. While the Bollinger Bands show a bullish signal on the monthly timeframe, the overall indicators suggest weakness in the current price action. The Dow Theory indicates a mildly bullish stance on the weekly chart but is mildly bearish on the monthly, reflecting mixed signals. The stock has underperformed compared to the Sensex over the YTD and 1Y periods, further supporting the bearish outlook....

View All News

Announcement

Board Meeting Intimation for Board Meeting Intimation Under Regulation 29 Of SEBI (LODR) Regulations 2015

30-Jan-2026 | Source : BSE

Shilpa Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve We hereby wish to inform you that the Meeting of the Board of Directors of Shilpa Medicare Limited is scheduled on Friday 06 February 2026 inter alia to consider and approve unaudited financial results of the Company (Consolidated and Standalone) for the quarter & nine months ended 31 December 2025.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

30-Jan-2026 | Source : BSE

Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith the schedule of 3Q- FY26 Earnings Conference Call which is to be held on Friday 06 February 2026 at 16.00 hrs.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

28-Jan-2026 | Source : BSE

Press release of Shilpa Biologicals Pvt Ltd a material subsidiary of Shilpa Medicare Limited. and mAb Tree Biologicals on achieving a Major U.S. FDA Milestone as Flagship Breakthrough Biologic secures orphan drug designation for rare blood cancers.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

Shilpa Medicare Ltd has declared 100% dividend, ex-date: 17 Sep 25

SPLITS

Shilpa Medicare Ltd has announced 1:2 stock split, ex-date: 06 Nov 15

BONUS

Shilpa Medicare Ltd has announced 1:1 bonus issue, ex-date: 03 Oct 25

RIGHTS

No Rights history available

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support@mojoinfinity.com, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."